These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7823521)

  • 1. [The COMOD system. A preservative-free multidose container for eyedrops].
    Teping C; Wiedemann B
    Klin Monbl Augenheilkd; 1994 Oct; 205(4):210-7. PubMed ID: 7823521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
    Tan DT; Chee SP; Lim L; Lim AS
    Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimally inflammatory cataract surgery].
    Hessemer V; Schmidt KG; Schartner H
    Klin Monbl Augenheilkd; 1996 Dec; 209(6):331-9. PubMed ID: 9091708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification.
    Wadood AC; Armbrecht AM; Aspinall PA; Dhillon B
    J Cataract Refract Surg; 2004 Apr; 30(4):761-8. PubMed ID: 15093636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.
    Kim MS; Choi CY; Kim JM; Chang HR; Woo HY
    Br J Ophthalmol; 2008 Nov; 92(11):1518-21. PubMed ID: 18782802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].
    Levrat F; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 1999 Mar; 22(2):186-91. PubMed ID: 10327349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pros and cons of preservatives in eyedrops. Questionnaire for practitioners and experimental studies with reference to the requirements of the German Pharmacopoeia of August 1978].
    Conrads H; Winterhoff D; Strotmann U
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):233-7. PubMed ID: 6727243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-use study of potential bacterial contamination of ophthalmic moxifloxacin.
    Mason BL; Alfonso EC; Miller D
    J Cataract Refract Surg; 2005 Sep; 31(9):1773-6. PubMed ID: 16246782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is subconjunctival steroid administration in addition to local therapy after cataract operations necessary? A laser tyndallometric study].
    Schmitt K; Hessemer V
    Ophthalmologe; 1995 Jun; 92(3):303-6. PubMed ID: 7655203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexamethasone eyedrops on blood glucose profile.
    Bahar I; Rosenblat I; Erenberg M; Eldar I; Gaton D; Avisar R; Weinberger D
    Curr Eye Res; 2007 Sep; 32(9):739-42. PubMed ID: 17882705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial agents in eyedrops].
    Sklubalová Z
    Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial contamination of eye drops.
    Taşli H; Coşar G
    Cent Eur J Public Health; 2001 Aug; 9(3):162-4. PubMed ID: 11505742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?
    German EJ; Hurst MA; Wood D
    Eye (Lond); 1999; 13 ( Pt 1)():93-100. PubMed ID: 10396391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing.
    Stevens JD; Matheson MM
    Br J Ophthalmol; 1992 Jan; 76(1):36-8. PubMed ID: 1739689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the effectiveness of the postsurgical mono- or combination therapy after cataract operations].
    Moustafa B; Hille K
    Klin Monbl Augenheilkd; 2007 Nov; 224(11):837-42. PubMed ID: 18034397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using multidose eyedrops in a health care setting: a policy and procedural approach to safe and effective treatment of patients.
    Jensen MK; Nahoopii R; Johnson B
    JAMA Ophthalmol; 2014 Dec; 132(12):1476-9. PubMed ID: 25188508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of microbial contamination in unpreserved eyedrops.
    Oldham GB; Andrews V
    Br J Ophthalmol; 1996 Jul; 80(7):588-91. PubMed ID: 8795368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.